Wiles is leaving. The MAHA fight still leads back to Trump.

That contradiction sits at the center of a public rupture within the Make America Healthy Again movement as Susie Wiles leaves the White House. Means, a former senior adviser to Health and Human Services Secretary Robert F. Kennedy Jr., alleges that Wiles and other officials put industry access and election fundraising ahead of voters’ health. Wiles and deputy chief of staff James Blair deny specific parts of his account. The accusations are not findings of corruption, and her departure does not establish that Means brought her down.⁠1

In an interview with CBS’s Margaret Brennan aired Sunday, November 8, Means said a group of former lobbyists catered to vaping, processed-food, pharmaceutical and pesticide interests, using the justification that “we need their money for the midterms.” He alleged that Wiles and a close circle of advisers “were taking money from the industries we ran on fighting against.” Those are serious accusations, but the account does not establish an unlawful payment, personal enrichment or a criminal bargain.⁠1

The detailed allegations, denials and accounts of internal deliberations come principally from one CBS report, also published across its regional sites. Those editions are not independent corroboration. CBS separately obtained statements from named officials and accounts from people familiar with the personnel and policy decisions.⁠1⁠2⁠3

A U.S. official and a senior White House adviser told CBS that Wiles submitted her resignation Thursday night. Three people familiar with her departure linked it to Republicans’ midterm defeats. That is a reported explanation, not a publicly verified statement of her reason for leaving. Means openly acknowledged wanting her removed, but the sequence leaves the effect of his intervention unresolved.⁠1

The distinction matters: Thursday’s private recording, Thursday night’s reported resignation and Friday’s public allegations were different events. CBS said it remained unclear whether Means’s public remarks affected Trump’s decision to expedite Wiles’s departure. Proximity is not proof of causation.⁠1

Means is not an outside critic. He helped found MAHA and build the Trump–Kennedy alliance in 2024, then worked on federal dietary guidelines and efforts to exclude soda and candy from purchases using food-assistance benefits. He resigned in October while expressing respect for both men. His present argument preserves that loyalty by assigning responsibility largely to the people around them.⁠1

The clearest test of that argument concerns fruit-flavored e-cigarettes. Means alleges that Wiles and Blair repeatedly pushed HHS to find a route to approval. The Food and Drug Administration approved some fruit-flavored products in early May—an earlier policy action, not a new announcement accompanying this dispute.⁠1

“I didn’t promote flavored vaping specifically at all,” Blair told CBS. He described his assignment as making the FDA approve or deny nicotine-device applications within six months, his explanation of the legal timetable. He accused Means of deliberately misrepresenting that administrative responsibility because Means opposed the policy. Faster decisions and pressure for a particular outcome are different things; the dispute turns partly on which was being sought.⁠1

Two people familiar with the process told CBS that Trump directed Blair to press then-FDA Commissioner Marty Makary for faster responses to nicotine-industry applications. They also said Trump wanted flavored vapes more widely available. That account does not settle whether every intervention was improper, but it places the president inside the policy push. During the 2024 campaign, Trump promised to “save” vaping, presenting it as an alternative to smoking and attracting support from e-cigarette companies, shop owners and enthusiasts.⁠1

Makary, who was pressed to resign in May amid the conflict, gave a sharply different account of the pressure: “Big tobacco exploited their connections to administration and HHS officials to put repeated pressure on me to approve fruit-flavored vapes that appeal to children—I wouldn’t do it.” His statement establishes his objection, not the conduct of every official Means names. The underlying policy tension is real: adults seeking alternatives to cigarettes and children’s exposure to appealing nicotine products are different public-health concerns.⁠1

Multiple people familiar with a lunch at Trump’s Florida golf course confirmed to CBS that tobacco lobbyists pressed the president about e-cigarette regulation. Means says Wiles arranged it; Wiles specifically denies doing so. Evidence that the meeting happened does not establish who organized it.⁠1

Means also targets White House policy aide Heidi Overton, whom Trump nominated to lead the FDA in August with Kennedy’s endorsement. He alleges that she told Makary she could not help him on other policies unless he approved Moderna’s mRNA flu vaccine, mFLUSIVA. Means says Makary believed it should not be approved on scientific grounds. Overton’s spokesman defended her qualifications by pointing to support from two former FDA commissioners, without specifically resolving the alleged conversation.⁠1

The pressure allegation is not evidence that the vaccine is unsafe or ineffective. The FDA approved mFLUSIVA in August for adults 50 and older, making it the first FDA-approved influenza vaccine using mRNA technology. CBS reports that clinical trials found it slightly more effective than the standard flu shot. Earlier in the year, the agency had refused to consider Moderna’s application before reversing course about a week later. Kennedy’s cancellation of 22 mRNA vaccine-development projects in 2025 adds evidence of an administration divided over the technology, not proof that this approval lacked scientific support.⁠1

On pesticides, Trump signed an executive order earlier in 2026 to increase production of glyphosate, the herbicide used in Roundup. Its classification as “probably carcinogenic to humans” describes a cancer hazard, not a finding that every exposure causes cancer. Kennedy, who spent years challenging Monsanto over glyphosate as a private attorney, told Congress in March that he objected to the order. He said it originated with the Pentagon and that Trump considered it necessary for national security. Here again, the president was making a choice, not simply being bypassed.⁠1

Means alleges that Overton worked with the Justice Department on a brief urging the Supreme Court to take Monsanto’s case over failure-to-warn liability. A senior White House official told CBS that the solicitor general wrote the brief at the Court’s request and that Overton’s final-stage changes concerned “tone.” That response acknowledges involvement while disputing its significance. In June, the Court sided with Monsanto over the warning claims; the administration had argued that federal standards superseded state-level liability claims. Means’s additional allegations involving ghostwritten research and bribery in an earlier EPA review remain unsubstantiated here.⁠1

Food policy supplies another unresolved claim: Means says industry lobbying stalled work on a federal definition of ultra-processed food because companies feared greater consumer transparency. Food-company shares rose on the day he resigned, but that coincidence cannot establish investors’ motives. He has also requested preservation of records connected with his allegations—a step toward seeking evidence, not evidence in itself.⁠1⁠24

Attorney General Todd Blanche dismissed Means’s allegations, Axios reported. That dismissal does not provide an issue-by-issue rebuttal or establish the truth or falsity of the specific claims.⁠4

Means praises Miller as willing to pursue structural changes with Trump and Kennedy. Yet no reversal of the vaping, vaccine or pesticide decisions has been established. The EPA’s continuing glyphosate review is expected to conclude in early 2027. Wiles’s replacement changes who controls access and coordination at the White House; it does not, by itself, change policy. The meaningful test is whether Miller’s arrival produces documented decisions and verifiable answers—not simply a new gatekeeper whom Means trusts more.⁠1